Kaspi.kz: Dividend Raise, Despite Hepsiburada Likely Still Dragging

Kaspi maintains a Buy rating as fintech loan growth remains strong, with lending shifting toward longer-duration, higher-revenue loans and improving credit quality. A dividend increase supports shareholder returns, while Kazakhstan's recent rate cut should lower funding costs and expand margins in KSPI's interest-sensitive businesses. The outlook also anticipates a potential Hepsi inflection in 2027.

Analysis

KSPI’s near-term earnings sensitivity is likely more levered to lower local funding costs than consensus models capture, because deposit repricing can occur faster than the asset yield reset on a growing longer-tenor loan book. The key question is whether this margin benefit survives competitive deposit pricing; if banks retain a meaningful portion of the rate cut, a modest net-interest-margin expansion can compound with loan growth over the next 1-3 quarters. Better credit trends reduce the probability that faster lending converts into elevated provisions, but this must be verified through cost-of-risk rather than management commentary.

HEPS is the higher-beta, less immediately monetizable optionality in the setup. Any operational inflection is unlikely to matter to consolidated valuation until there is evidence of improved contribution margins, customer retention, and reduced cash consumption; a 2027 narrative alone should receive a steep discount rate. The second-order benefit to KSPI is strategic: a credible Turkish turnaround could shift investor perception from Kazakhstan-fintech exposure toward a regional platform multiple, but Turkey’s FX, inflation and regulatory risks can equally create a conglomerate discount.

Consensus appears focused on the earnings tailwind and shareholder return while underweighting duration mismatch and geographic-risk transmission. A faster-than-expected Kazakhstan easing cycle could eventually compress asset yields and erase the initial margin expansion; conversely, stable loan yields alongside deposit-cost relief would be the clearest upside catalyst. Over 6-18 months, the more important structural variable is whether incremental loans maintain loss performance through a full credit cycle, not the headline growth rate.

Key Decisions for Investors

• Maintain/establish a 3-6 month long KSPI position ahead of quarterly results; target upside is driven by upward NII and provision estimates if NIM expands and cost of risk remains contained. Falsify on a material sequential NIM decline, cost of risk above management’s normalized range, or deposit-cost competition absorbing the policy-rate benefit.
• Express the relative view via long KSPI / short a broad emerging-market fintech proxy such as ARKF or EMQQ over 3-6 months, sizing the hedge modestly because KSPI’s primary risks are Kazakhstan-specific liquidity and currency exposure rather than global fintech beta.
• Do not underwrite HEPS as a standalone long solely on a 2027 inflection thesis. Put it on an earnings watchlist: consider a small, catalyst-driven long only after two consecutive quarters of improving adjusted EBITDA/contribution margin and evidence that cash burn is narrowing; otherwise HEPS remains a source of valuation-discount risk within the KSPI story.
• Before increasing KSPI exposure, monitor Kazakhstan deposit rates versus loan yields monthly and quarterly stage-3/NPL formation. A rapid decline in asset yields or renewed FX pressure would warrant reducing the position even if reported loan growth remains strong.